2002

1. Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancer

   BJU International, Vol. 89, Núm. 7, pp. 671-680